Powder Delivery TRIZ Cases

Hydrophobic licorice extract containing glabridin binds to transthyretin tetramers to stabilize their structure.

Neutralizing anti-VP1 antibodies bind viral capsid proteins to prevent infection while maintaining immunosuppression levels.

Sealing the discharge passageway with a desiccant reduces moisture infiltration and prevents medicament deposition in metered dose inhalers.

Spray-dried cannabinoid particles bypass the stomach to deliver active ingredients directly to the lungs, reducing time to peak plasma concentration.

An oscillating actuator within a dispersion chamber mechanically deaggregates powdered medicament entrained in airflow.

A dry hemostatic composition merges thrombin and biocompatible polymer in a single container for one-step reconstitution.

Cyclic A-beta peptides expose conformational epitopes to enable selective antibody binding against Alzheimer's targets.

Fucoidan nanogels overcome endothelial barriers by targeting P-selectin, enabling pH-sensitive drug release in tumors.

Oxamide bonds control carbon dioxide generation rates, enabling perfluorohexane capture and resolving low signal enhancement from rapid reaction kinetics.

Peptide-based hydrogels self-assemble into rigid scaffolds, resolving toxicity from chemical crosslinking agents.

Calcium phosphate nanoparticles encapsulate near-infrared photosensitizers to extend half-life and enable deep tissue penetration for targeted tumor treatment.

Spray-dried inhalable growth hormone powder improves bioavailability and patient compliance over subcutaneous injections.

Host-guest interactions selectively extract interfering nanoparticles from plasma, restoring clinical laboratory test accuracy.

Applying PDGF in a biocompatible matrix accelerates bone consolidation, increasing mineral content and tensile strength of regenerated bone.

High shear miniemulsion polymerization creates stable hydrophobic drug dispersion, increasing loading efficiency while eliminating toxic solubilizing agents.

High atomic number nanoparticles absorb radiation locally to enhance DNA strand breaks in cancer cells while minimizing damage to healthy tissue.

Heating reflux extraction of tannin compounds yields spherical catechol nanoparticles, resolving irregular morphology and complex manufacturing bottlenecks.

Biocompatible mineral microparticles selectively adsorb tumor antigens from patient extracts to enable single-step purification and immune system vectorization.

Optimizing nanoparticle diameter and zeta potential enables targeted mitochondrial accumulation while reducing cellular toxicity.

A continuous roll-to-roll freeze-drying system integrates a metrology section to monitor sublimation rates and sheet thickness during processing.

Segmented dosage overcomes food-induced absorption reduction, enabling dosing within two hours of eating while maintaining therapeutic plasma levels.

Spray dried microcrystalline diketopiperazine particles adsorb drugs into hollow shells, overcoming pulmonary delivery instability.

Vacuum sublimation of frozen residual liquid preserves peptide activity on high pH inorganic particles.

Nanoparticle carriers deliver taurolidine hydrolysis products to neuroblastoma sites, preventing premature degradation and improving survival rates.

Replacing sodium hydride with safer bases prevents deschloro impurities during pitolisant hydrochloride synthesis, eliminating tedious purification steps.

Citrate buffer maintains IgG4 binding agent formulations at or below the isoelectric point to ensure high-concentration stability.

Segmented multi-layered hydrogel restores zonal organization by sequentially releasing growth factors, preventing fibrocartilage formation.

A block copolymer hydrogel transitions between sol and gel states via pH and temperature changes.

Terpene carriers facilitate cannabidiol transport across the blood-brain barrier, bypassing slow digestive processing.

Lipid nanoparticles encapsulate mRNA encoding SARS-CoV-2 spike antigens, resolving stability and immunogenicity trade-offs.

Composite acrylic hydrogel and phosphazene microspheres resolve imaging visibility versus biocompatibility trade-offs in targeted embolization therapy.

Replacing toxic diisocyanates with gelatin and calcium carbonate maintains structural integrity while ensuring biocompatibility for wound healing.

Inhaled proinflammatory cytokine inhibitors reduce lower airway inflammation via targeted aerosol delivery.

Porous silica particles with 5 nm to 100 nm pores support nucleic acids, resolving cell toxicity issues linked to cationic liposomes.

Cyclic peptide ligands covalently bond nanoparticles to improve binding affinity while reducing side effects from limited receptor specificity.

Crystalline mono mesylate monohydrate salt with controlled particle size distribution resolves poor stability and low solubility of the free base form.

Lipid nanoparticle mRNA delivers ornithine transcarbamylase protein to restore enzyme function.

An inhalation pharmaceutical composition merges atomized levodopa with hydrogen gas to enhance drug absorption and patient convenience.

Cationic lipopolymers condense nucleic acids into stable compositions, preventing aggregation during high-concentration clinical dosing.

Segmenting aluminum into nanoparticles resolves low cellular induction efficiency in traditional adjuvants while improving antigen storage capacity.

Combining a high-affinity polypeptide with probiotics reduces IgE levels and mast cell numbers without triggering IgG-mediated anaphylaxis.

Nanoparticles coated with MHC and co-stimulatory molecules expand antigen-specific anti-tumorigenic T cells to overcome insufficient tumor clearance.

Surface-modified nanoparticles coat dry powder pharmaceutical compositions to enhance respirable fraction and delivery efficiency.

pH-sensitive unimolecular nanoparticles deliver cationic peptides to cancer cells, inhibiting PKM2 methylation and reducing proliferation.

A powder film coating composition disperses in water to form a protective barrier on solid dosage forms.

A water-soluble barrier layer separates acid particles from peptide agents to prevent premature degradation.

CVD silicon particles improve oral bioavailability by protecting drugs from gut instability.